Franck E Nicolini

Franck E Nicolini

UNVERIFIED PROFILE

Are you Franck E Nicolini?   Register this Author

Register author
Franck E Nicolini

Franck E Nicolini

Publications by authors named "Franck E Nicolini"

Are you Franck E Nicolini?   Register this Author

60Publications

2039Reads

8Profile Views

Molecular monitoring of patients with ETV6-PDGFRB rearrangement: Implications for therapeutic adaptation.

Br J Haematol 2018 07 9;182(1):148-152. Epub 2017 May 9.

Laboratoire d'Hématologie, CHU de Brest and INSERM U1078, Université de Bretagne Occidentale, Brest, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14748DOI Listing
July 2018

Stability Analysis of a Model of Interaction Between the Immune System and Cancer Cells in Chronic Myelogenous Leukemia.

Bull Math Biol 2018 05 23;80(5):1084-1110. Epub 2017 May 23.

Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5208, Institut Camille Jordan, 43 blvd. du 11 novembre 1918, F-69622, Villeurbanne cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11538-017-0272-7DOI Listing
May 2018

Immature CML cells implement a BMP autocrine loop to escape TKI treatment.

Blood 2017 12 14;130(26):2860-2871. Epub 2017 Nov 14.

Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-08-801019DOI Listing
December 2017

Potential anti-leukemic activity of iron chelation after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia.

Leuk Lymphoma 2017 01 31;58(1):237-240. Epub 2016 May 31.

a Hematology Department 1G , Centre Hospitalier Lyon Sud, Hospices Civils de Lyon , Pierre Bénite , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1185787DOI Listing
January 2017

BCR-ABL transcript variations in chronic phase chronic myelogenous leukemia patients on imatinib first-line: Possible role of the autologous immune system.

Oncoimmunology 2016 May 8;5(5):e1122159. Epub 2016 Jan 8.

Department of Mathematics and Center for Scientific Computation and Mathematical Modeling (CSCAMM), University of Maryland , College Park, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1122159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910749PMC
May 2016

Membranous glomerulonephritis as a novel paraneoplastic syndrome in a young man with chronic myeloid leukemia.

Leuk Lymphoma 2016 Feb 18;57(2):483-485. Epub 2015 Jul 18.

f Paediatric Haematology, Institut Hematologie et Oncologie Pediatrique, Hospices Civils de Lyon, Groupement Hospitalier Est , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1061188DOI Listing
February 2016

Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients.

Blood 2016 Feb 24;127(6):703-12. Epub 2015 Nov 24.

Department of Genetics and Molecular Pathology, SA Pathology, Centre for Cancer Biology, School of Medicine and School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia; and School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-08-660977DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760131PMC
February 2016

Implication of the Autologous Immune System in BCR-ABL Transcript Variations in Chronic Myelogenous Leukemia Patients Treated with Imatinib.

Cancer Res 2015 Oct 10;75(19):4053-62. Epub 2015 Sep 10.

Department of Mathematics and Center for Scientific Computation and Mathematical Modeling (CSCAMM), University of Maryland, College Park, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-0611DOI Listing
October 2015

Deciphering the internal complexity of living cells with quantitative phase microscopy: a multiscale approach.

J Biomed Opt 2015 Sep;20(9):096005

CNRS UMR5672, Laboratoire de Physique, Ecole Normale Supérieure de Lyon, 46 Allée d'Italie, 69007 Lyon, FrancebUniversité de Lyon 1, 43 Boulevard du 11 Novembre 1918, 69100 Villeurbanne, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1117/1.JBO.20.9.096005DOI Listing
September 2015

Effect of Initial Body Mass Index on Survival Outcome of Patients With Acute Leukemia: A Single-Center Retrospective Study.

Clin Lymphoma Myeloma Leuk 2015 Jun;15 Suppl:S7-13

Hospices Civils de Lyon, Lyon-Sud Hospital, Hematology Department, Pierre Bénite, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.02.005DOI Listing
June 2015

Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease.

J Clin Oncol 2014 Feb 9;32(5):424-30. Epub 2013 Dec 9.

Philippe Rousselot, Hôpital Mignot, Université Versailles Saint-Quentin-en-Yvelines, Versailles; Aude Charbonnier, Institut Paoli Calmette, Marseille; Pascale Cony-Makhoul, Hôpital d'Annecy, Pringy; Philippe Agape, Hôpital Felix Guyon-Centre Hospitalier Universitaire en France (CHU) de la Réunion, La Réunion; Franck E. Nicolini, Centre Hospitalier Lyon Sud, Pierre-Bénite; Bruno Varet, Hôpital Necker, Assistance Publique-Hopitaux de Paris (AP-HP) et Université Paris Descartes; Delphine Réa and Jean Michel Cayuela, Hôpital Saint-Louis, AP-HP, Paris; Martine Gardembas, CHU d'Angers, Angers; Gabriel Etienne and Josy Reiffers, Institut Bergonié; François-Xavier Mahon, Hôpital Haut-Levèque et Université Bordeaux Ségalen, Bordeaux; Lydia Roy, Joëlle Guilhot, and François Guilhot, Institut National de la Santé et de la Recherche Médicale (INSERM) Centres d'Investigation Clinique CHU de Poitiers, Poitiers; Martine Escoffre-Barbe, Centre Hospitalier Pontchaillou, Rennes; Agnès Guerci-Bresler, CHU Brabois Vandoeuvre, Nancy; Michel Tulliez, Hôpital Henri Mondor, AP-HP, Créteil; Stéphane Prost, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Institute of Emerging Diseases and Innovative Therapies, Fontenay-aux-Roses; Marc Spentchian, Hôpital Mignot, Le Chesnay; and Jean Claude Chomel and Ali Turhan, INSERM U935, Université Poitiers et Paris Sud, Le Kremlin Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.5797DOI Listing
February 2014

Primitive CML cell expansion relies on abnormal levels of BMPs provided by the niche and on BMPRIb overexpression.

Blood 2013 Nov 7;122(23):3767-77. Epub 2013 Oct 7.

Centre National de la Recherche Scientifique Unité Mixte de Recherche UMR5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-05-501460DOI Listing
November 2013

New Quantitative Method to Identify NPM1 Mutations in Acute Myeloid Leukaemia.

Leuk Res Treatment 2013 9;2013:756703. Epub 2013 Apr 9.

Laboratoire d'Hématologie, Centre Hospitalier Lyon Sud, 165 chemin du Grand Revoyet, 69 495 Pierre-Bénite, France ; UMR 5239 CNRS, Faculté de Médecine Lyon Sud, 165 chemin du Petit Revoyet-BP 12, 69921 Oullins Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2013/756703DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649360PMC
May 2013

Quantitation of murine and human hematopoietic stem cells by limiting-dilution analysis in competitively repopulated hosts.

Methods Mol Med 2002 ;63:167-87

Lucille P. Markey Cancer Center, University of Kentucky, Lexington, KY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/1-59259-140-X:167DOI Listing
October 2012

Longitudinal studies of SRC family kinases in imatinib- and dasatinib-resistant chronic myelogenous leukemia patients.

Leuk Res 2011 Jan 29;35(1):38-43. Epub 2010 Jul 29.

Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Laboratory for Molecular Biology and UMR5239 CNRS, Pierre-Bénite, France.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S014521261000322
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2010.06.030DOI Listing
January 2011

BCR-ABL mutant kinetics in CML patients treated with dasatinib.

Leuk Res 2007 Jun 8;31(6):865-8. Epub 2007 Jan 8.

Hematology Department, Hôpital Edouard Herriot, 5 place d'Arsonval 69437 Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2006.12.003DOI Listing
June 2007

Assessment and follow-up of the proportion of T315I mutant BCR-ABL transcripts can guide appropriate therapeutic decision making in CML patients.

Leuk Res 2005 Sep 23;29(9):1073-7. Epub 2005 Mar 23.

Laboratoire d'ématologie et de Cytogénétique, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2005.02.006DOI Listing
September 2005